Ms. Benjamin is senior director, corporate responsibility and global health programs. She also serves as president of the Eli Lilly and Company Foundation. In her senior director role, she manages the company’s civic engagement, corporate social responsibility efforts, disaster relief efforts, and global health initiatives.
Prior to that, she was senior director, litigation and legal compliance at Eli Lilly and Company. In that role, she heads the company’s non-patent litigation group, managing the company’s product liability, complex commercial, and human resources litigation. From 2015 to 2017, she served as the company’s assistant general counsel, assistant corporate secretary. In that role, she served as the company’s securities counsel and corporate governance counsel, as well as assistant secretary to the Board of Directors. From 2013 to 2015, she served as the company’s anti-corruption counsel and legal counsel on the company’s privileged internal investigation process.
Prior to joining Lilly, Ms. Benjamin served as senior investigative counsel for the Democratic Staff of U.S. House of Representatives Energy and Commerce Committee, working on investigations into national matters including the Deepwater Horizon oil spill, the Wal-Mart Mexico bribery allegations, the 2012 fungal meningitis outbreak, and the Solyndra loan guarantee investigation.
Before joining the Committee, she worked as an associate in the D.C. office of King and Spalding, as a member of its Special Matters team, handling white collar matters and government investigations. Ms. Benjamin has a law degree from Harvard Law School and an undergraduate degree from Indiana University.